Tag: automated cell culture equipment market overview

  • Automated Cell Culture Equipment Market Growth Prospects 2026–2030 with Innovation Trends and Competitive Landscape

    Automated Cell Culture Equipment Market Growth Prospects 2026–2030 with Innovation Trends and Competitive Landscape

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Market Valuation Is Forecasted For The Automated Cell Culture Equipment Market By 2030 Starting From Its 2026 Size?

    The automated cell culture equipment market size has seen swift expansion in recent years. This market is anticipated to rise from $2.32 billion in 2025 to $2.6 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.9%. Historically, the market’s expansion can be attributed to the growth in pharmaceutical and biologics research, an increasing need for consistent cell culture outcomes, the broadening of drug discovery pipelines, the escalating complexity of cell-based assays, and the early adoption of laboratory automation.

    The automated cell culture equipment market is poised for significant expansion in the coming years. Its value is projected to reach $4.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.6%. This anticipated growth stems from several factors, including increasing investments in regenerative medicine, the widening scope of cell and gene therapy pipelines, a rising need for scalable cell culture solutions, a greater emphasis on minimizing laboratory variability, and the expanding integration of AI-driven lab automation. Key developments expected during this period involve the increasing adoption of fully automated cell culture platforms, the growing use of high-throughput cell processing systems, enhanced incorporation of robotics and imaging technologies, the expansion of closed-system and contamination-controlled workflows, and a heightened focus on reproducibility and process standardization.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=30201&type=smp

    What Primary Drivers Are Shaping The Development Of The Automated Cell Culture Equipment Market?

    The increasing embrace of personalized medicine is anticipated to fuel the expansion of the automated cell culture equipment market. Personalized medicine involves customizing medical care based on an individual’s genetic makeup, lifestyle choices, and environmental influences to achieve more accurate and impactful treatment. The growing acceptance of personalized medicine stems from its ability to offer more potent treatments, as therapies are specifically designed for an individual’s genetic and biological profile, leading to enhanced patient results. Automated cell culture equipment plays a crucial role in advancing personalized medicine by delivering accurate, high-volume, and consistent cell culture procedures that aid in developing patient-specific therapies and customized drug assessments. For example, in February 2024, the US-based non-profit, Personalized Medicine Coalition, revealed that in 2023, the FDA sanctioned 16 novel personalized treatments for individuals with rare diseases, marking a substantial increase from the six approved in 2022. Consequently, the escalating adoption of personalized medicine is powering the growth of the automated cell culture equipment market.

    Which Segment Categories Define The Automated Cell Culture Equipment Market?

    The automated cell culture equipment market covered in this report is segmented –

    1) By Product Type: Instruments, Consumables, Software

    2) By Automation Level: Fully Automated Systems, Semi-Automated Systems, Manual Systems With Automation Features

    3) By Application: Drug Discovery And Development, Regenerative Medicine, Toxicology Testing, Vaccine Development, Stem Cell Research

    4) By End-User: Pharmaceutical Companies, Biotechnology Companies, Academic And Research Institutions, Contract Research Organizations (CROs), Diagnostics And Testing Laboratories

    Subsegments:

    1) By Instruments: Automated Cell Culture Systems, Bioreactors, Incubators, Centrifuges, Cell Counters And Analyzers, Liquid Handling Systems, Cell Imaging Systems, Robotic Arms And Manipulators, Cell Harvesting Systems, Filtration And Separation Devices

    2) By Consumables: Culture Media, Reagents And Supplements, Microplates And Culture Dishes, Flasks And Bottles, Single-Use Bags And Tubing, Filters And Membranes, Pipette Tips And Cartridges, Cell Culture Inserts, Sterile Connectors And Clamps

    3) By Software: Data Management Software, Process Control And Monitoring Software, Laboratory Information Management Systems (LIMS), Image Analysis Software, Workflow Automation Software, Quality Control And Compliance Software, Remote Monitoring And Cloud Integration Tools

    Which Upcoming Trends Are Expected To Influence The Automated Cell Culture Equipment Market?

    Leading companies within the automated cell culture equipment market are concentrating on innovations in seamless workflow integration, particularly closed single-use consumable systems, to improve process standardization, mitigate contamination risks, minimize manual handling, and enable efficient scaling from research to clinical manufacturing. A closed single-use consumable system represents a sterile, disposable setup that consolidates multiple cell culture processes into one unit, thereby lowering contamination risks and facilitating scalable, reproducible workflows. For example, in March 2025, Limula SA, a biotechnology company based in Switzerland specializing in automated cell therapy manufacturing solutions, introduced LimONE, an integrated system that combines hardware, software, and single-use consumables to simplify and standardize cell culture and processing workflows. This introduction establishes a commercial product serving both research and GMP-compliant manufacturing sectors. LimONE facilitates quicker technology transfer, reduces labor and infrastructure costs, and supports the scalable production of advanced cell therapies, including CAR-T and gene-edited stem cells. The system boosts workflow efficiency and ensures reproducibility across various cell therapy processes. Overall, this product launch strengthens Limula’s presence in the automated cell culture equipment market while supporting regulatory compliance.

    Who Are The Top Companies Competing In The Automated Cell Culture Equipment Market?

    Major companies operating in the automated cell culture equipment market are F. Hoffmann-La Roche Ltd, Hitachi Ltd., Merck KGaA, Panasonic Holdings Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Corning Incorporated, Lonza Group AG, Olympus Corporation, Sartorius AG, Eppendorf SE, Tecan Group Ltd., STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Hamilton Company, Greiner Bio-One International GmbH, Solida Biotech GmbH, Biostream International B.V., HiMedia Laboratories Pvt. Ltd., Kuhner Shaker AG, Cellexus International Ltd.

    Read the full automated cell culture equipment market report here:

    https://www.thebusinessresearchcompany.com/report/global-automated-cell-culture-equipment-market-report

    How Does The Automated Cell Culture Equipment Market Perform Across Major Global Regions?

    North America was the largest region in the automated cell culture equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated cell culture equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Automated Cell Culture Equipment Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=30201&type=smp

    Browse Through More Reports Similar to the Global Automated Cell Culture Equipment Market 2026, By The Business Research Company

    Cell Cultures Global Market Report

    https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

    Cell Cultures Global Market Report

    https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

    Cell Culture Media Global Market Report

    https://www.thebusinessresearchcompany.com/report/cell-culture-media-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Automated Cell Culture Equipment Market Anticipated to Record Steady Gains, Advancing to $4.02 Billion by 2030

    Automated Cell Culture Equipment Market Anticipated to Record Steady Gains, Advancing to $4.02 Billion by 2030

    Uncover key drivers, emerging technologies, and competitive movements shaping the automated cell culture equipment market from 2026–2035 with trusted insights from The Business Research Company

    What level of CAGR-driven expansion is anticipated in the Automated Cell Culture Equipment Market between 2026 and 2030?

    The automated cell culture equipment market size has demonstrated rapid expansion in recent years. It is projected to increase from $2.32 billion in 2025 to $2.6 billion in 2026, reflecting a compound annual growth rate (CAGR) of 11.9%. The historical growth experienced by this market can be attributed to factors such as the rise in pharmaceutical and biologics research, a heightened demand for consistent cell culture outcomes, the expansion of drug discovery pipelines, the increasing complexity of cell-based assays, and the early adoption of laboratory automation.

    The automated cell culture equipment market is set to experience significant expansion in the coming years, with its value projected to reach $4.03 billion by 2030, driven by a compound annual growth rate (CAGR) of 11.6%. This anticipated growth is largely due to increased investments in regenerative medicine, the ongoing development of cell and gene therapy pipelines, a rising demand for scalable cell culture solutions, a heightened focus on minimizing laboratory variability, and the growing adoption of AI-driven lab automation. Throughout this forecast period, major trends are expected to include the widespread deployment of fully automated cell culture platforms, a greater adoption of high-throughput cell processing systems, the deeper integration of robotics and imaging technologies, an expansion of closed-system and contamination-controlled workflows, and an enhanced emphasis on reproducibility and process standardization.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=30201&type=smp

    What Drivers Are Affecting Demand-Supply Dynamics In The Automated Cell Culture Equipment Market?

    The increasing acceptance of personalized medicine is anticipated to stimulate the expansion of the automated cell culture equipment market in the future. Personalized medicine involves customizing medical treatments for individuals based on their genetic, lifestyle, and environmental factors to achieve more precise and effective care. This rise in adoption is primarily driven by the greater efficacy of treatments, as therapies are tailored to an individual’s unique genetic and biological profile, thereby enhancing patient outcomes. Automated cell culture equipment supports personalized medicine by providing accurate, high-throughput, and reproducible cell culture processes, essential for developing patient-specific therapies and customized drug testing. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, which represents a significant increase from the six approved in 2022. Therefore, the growing adoption of personalized medicine is a key driver for the automated cell culture equipment market’s growth.

    What Segments Are Included Within The Automated Cell Culture Equipment Market?

    The automated cell culture equipment market covered in this report is segmented –

    1) By Product Type: Instruments, Consumables, Software

    2) By Automation Level: Fully Automated Systems, Semi-Automated Systems, Manual Systems With Automation Features

    3) By Application: Drug Discovery And Development, Regenerative Medicine, Toxicology Testing, Vaccine Development, Stem Cell Research

    4) By End-User: Pharmaceutical Companies, Biotechnology Companies, Academic And Research Institutions, Contract Research Organizations (CROs), Diagnostics And Testing Laboratories

    Subsegments:

    1) By Instruments: Automated Cell Culture Systems, Bioreactors, Incubators, Centrifuges, Cell Counters And Analyzers, Liquid Handling Systems, Cell Imaging Systems, Robotic Arms And Manipulators, Cell Harvesting Systems, Filtration And Separation Devices

    2) By Consumables: Culture Media, Reagents And Supplements, Microplates And Culture Dishes, Flasks And Bottles, Single-Use Bags And Tubing, Filters And Membranes, Pipette Tips And Cartridges, Cell Culture Inserts, Sterile Connectors And Clamps

    3) By Software: Data Management Software, Process Control And Monitoring Software, Laboratory Information Management Systems (LIMS), Image Analysis Software, Workflow Automation Software, Quality Control And Compliance Software, Remote Monitoring And Cloud Integration Tools

    What Upcoming Trends Are Likely To Define The Future Path Of The Automated Cell Culture Equipment Market?

    Companies active in the automated cell culture equipment market are concentrating on innovations in seamless workflow integration, such as closed single-use consumable systems, to boost process standardization, lower contamination risks, reduce manual handling, and allow for efficient scaling from research to clinical manufacturing. A closed single-use consumable system is a sterile, disposable setup that integrates multiple cell culture processes into one unit, effectively minimizing contamination risks and enabling scalable, reproducible workflows. For example, in March 2025, Limula SA, a Switzerland-based biotechnology company specializing in automated cell therapy manufacturing solutions, launched LimONE. This integrated system merges hardware, software, and single-use consumables to streamline and standardize cell culture and processing workflows. This launch introduces a commercial product catering to both research and GMP-compliant manufacturing sectors. LimONE facilitates faster technology transfer, decreases labor and infrastructure costs, and supports the scalable production of advanced cell therapies, including CAR-T and gene-edited stem cells. The system significantly improves workflow efficiency and guarantees reproducibility across various cell therapy processes. Overall, this product introduction solidifies Limula’s standing in the automated cell culture equipment market while simultaneously aiding regulatory compliance.

    Who Are The Prominent Global Companies Shaping The Automated Cell Culture Equipment Market Landscape?

    Major companies operating in the automated cell culture equipment market are F. Hoffmann-La Roche Ltd, Hitachi Ltd., Merck KGaA, Panasonic Holdings Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Corning Incorporated, Lonza Group AG, Olympus Corporation, Sartorius AG, Eppendorf SE, Tecan Group Ltd., STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Hamilton Company, Greiner Bio-One International GmbH, Solida Biotech GmbH, Biostream International B.V., HiMedia Laboratories Pvt. Ltd., Kuhner Shaker AG, Cellexus International Ltd.

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/global-automated-cell-culture-equipment-market-report

    Which Geographic Areas Are Emerging As Strong Markets For The Automated Cell Culture Equipment Market?

    North America was the largest region in the automated cell culture equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated cell culture equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Automated Cell Culture Equipment Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=30201&type=smp

    Browse Through More Reports Similar to the Global Automated Cell Culture Equipment Market 2026, By The Business Research Company

    Cell Culture Media Market Report 2026

    https://www.thebusinessresearchcompany.com/report/cell-culture-media-global-market-report

    Cell Cultures Market Report 2026

    https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

    Cell Cultures Market Report 2026

    https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model